Last May, research-based global biopharmaceutical firm AbbVie finalized a transformative acquisition of Allergan, an Ireland-headquartered healthcare solutions provider. The transaction made AbbVie, a relatively young spinoff of the long-established Abbott Laboratories, the fifth largest biopharmaceutical company in the world. It further diversified the company’s robust product portfolio, expanded and strengthened its already robust R&D pipeline,…

Taiwan has been under the international spotlight since its early intervention in the COVID-19 crisis, and its comprehensive virus-prevention measures have made it one of the world’s few safe havens during the pandemic. The increased visibility of this island powerhouse has also drawn attention to its strengths in the area of healthcare, including clinical research….

The healthcare industry is currently undergoing a radical transformation. Patients increasingly have access to better, more personalized treatment options targeting previously intractable illnesses, allowing them to live longer, more fulfilling lives. Yet for Novartis, this hard work is just the beginning of the long journey. While the global healthcare ecosystem continues to flourish, reaching ever…

The 2020 AmCham Taipei Longevity Forum 2.0 was held on November 11 at the Sherwood Hotel, drawing an audience of 90 members and their guests. The forum featured speakers and panelists from government, academia, and industry, allowing for a diverse range of viewpoints and an eye-opening discussion of the projected impact of Taiwan’s aging solutions…

Taiwan’s technical strengths will also benefit its economic recovery. Prior to the COVID-19 pandemic, Taiwan was already investing heavily in advanced manufacturing and networking technologies. It’s recent success in containing the spread of COVID-19 at home puts it in good standing to become a leader in a variety of next-generation platforms that can be employed…

Major healthcare multinational Johnson & Johnson’s credo states its commitment and responsibilities to the interests of all the company’s stakeholders. This pledge is engraved in English and Chinese on placards hung at the entrance to J&J’s Taiwan office. There, leadership and staff in the company’s three business sectors of consumer health, pharmaceuticals, and medical devices…